Alder BioPharmaceuticals

YTD

ALL

Why Robinhood?

You can watch ALDR and buy or sell other stocks, ETFs, and their options commission-free!

About ALDR

Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine.

CEO

Thomas Ripp

CEOThomas Ripp

Employees

—

Employees—

Headquarters

Bothell, Washington

HeadquartersBothell, Washington

Founded

2004

Founded2004

Employees

—

Employees—

ALDR Key Statistics

Market cap

1.58B

Market cap1.58B

Price-Earnings ratio

-4.24

Price-Earnings ratio-4.24

Dividend yield

—

Dividend yield—

Average volume

5.30M

Average volume5.30M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$19.12

52 Week high$19.12

52 Week low

$8.39

52 Week low$8.39